To include your compound in the COVID-19 Resource Center, submit it here.

Abzena, Baylor Scott & White Research Institute deal

Abzena and the institute formed JV Denceptor Therapeutics Ltd. to develop immunotherapies against cancer and

Read the full 154 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE